HH
MRVI icon

Hilltop Holdings’s Maravai LifeSciences MRVI Stock Holding History

Hilltop Holdings’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$469K Buy
+75,239
New +$325K 0.04% 434

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Hilltop Holdings's MRVI Position: Q2 2026 in Review

Hilltop Holdings opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 75,239 shares worth $469K. The stake represents 0.04% of the portfolio and ranks #434 among its holdings.

178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Hilltop Holdings held 75,239 shares of Maravai LifeSciences worth $469K as of Q2 2026.
  • Maravai LifeSciences was a new Hilltop Holdings position in Q2 2026.
  • Maravai LifeSciences made up 0.04% of Hilltop Holdings's portfolio in Q2 2026, its #434 holding.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Hilltop Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.